Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
AngloGold Ashanti
AU
$49.3B
| $235K | ﹤0.01% |
26,176
-1,095,924
| -98% | -$11.7M |
|
4102
CALL
BioCryst Pharmaceuticals
BCRX
$2.64B
| $235K | ﹤0.01% |
26,100
-74,400
| -74% | -$770K |
|
4103
CALL
Foster
FSTR
$398M
| $235K | ﹤0.01% |
5,000
+3,000
| +150% | +$142K |
|
4104
PUT
iShares Russell 1000 Growth ETF
IWF
$127B
| $235K | ﹤0.01% |
9,600
+4,800
| +100% | +$117K |
|
4105
PUT
Ryder
R
$9.92B
| $235K | ﹤0.01% |
2,500
-100
| -4% | -$9.19K |
|
4106
PUT
ProShares UltraShort Russell2000
TWM
$41.5M
| $235K | ﹤0.01% |
335
-1,625
| -83% | -$1.25M |
|
|
CKEC
4107
DELISTED
Carmike Cinemas Inc
CKEC
| $235K | ﹤0.01% |
7,125
+2,429
| +52% | +$72.1K |
|
4108
PUT
Box
BOX
$4.55B
| $234K | ﹤0.01% |
+12,300
| New | +$231K |
|
4109
First Citizens BancShares
FCNCA
$25.4B
| $234K | ﹤0.01% |
902
-656
| -42% | -$162K |
|
4110
PUT
Huntington Bancshares
HBAN
$35.9B
| $234K | ﹤0.01% |
21,300
-12,700
| -37% | -$134K |
|
|
ECOM
4111
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $234K | ﹤0.01% |
26,008
+17,057
| +191% | +$189K |
|
|
ASCMA
4112
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $234K | ﹤0.01% |
5,998
-1,973
| -25% | -$87.8K |
|
|
HK
4113
CALL
DELISTED
Halcon Resources Corporation
HK
| $234K | ﹤0.01% |
1,356
-1,087
| -44% | -$322K |
|
|
ACTA
4114
DELISTED
Actua Corp
ACTA
| $232K | ﹤0.01% |
15,446
-3,360
| -18% | -$54K |
|
4115
CALL
Itaú Unibanco
ITUB
$82.6B
| $231K | ﹤0.01% |
52,283
+16,738
| +47% | +$81.7K |
|
|
NUAN
4116
PUT
DELISTED
Nuance Communications, Inc.
NUAN
| $231K | ﹤0.01% |
19,058
-323,169
| -94% | -$3.9M |
|
4117
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
| $230K | ﹤0.01% |
1,900
-3,700
| -66% | -$449K |
|
4118
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $230K | ﹤0.01% |
5,740
+402
| +8% | +$16K |
|
|
XONE
4119
CALL
DELISTED
The ExOne Company
XONE
| $230K | ﹤0.01% |
17,700
-4,000
| -18% | -$59.6K |
|
|
MENT
4120
DELISTED
Mentor Graphics Corp
MENT
| $230K | ﹤0.01% |
9,551
-13,930
| -59% | -$326K |
|
4121
PUT
Jefferies Financial Group
JEF
$12.7B
| $229K | ﹤0.01% |
11,618
-52,129
| -82% | -$1.08M |
|
4122
Quad
QUAD
$502M
| $229K | ﹤0.01% |
10,431
-7,714
| -43% | -$171K |
|
4123
PUT
Sempra
SRE
$55.9B
| $229K | ﹤0.01% |
4,200
+1,600
| +62% | +$88.2K |
|
4124
CALL
CBRE Group
CBRE
$42.7B
| $228K | ﹤0.01% |
6,000
-14,800
| -71% | -$510K |
|
|
HOLX
4125
PUT
DELISTED
Hologic
HOLX
| $228K | ﹤0.01% |
6,900
-6,000
| -47% | -$184K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.